Deal Dive: Cutting through the noise in a category clouded by catastrophic failure

Building a startup is hard enough but growing one in a category marred with Theranos-sized stigma is a new level of challenge. Vital Bio seems up for the test.

The Toronto-based startup is building a machine, VitalOne, that can perform more than 50 blood tests — covering nearly all of those considered routine — and get patient results back in 20 minutes, not multiple days. Co-founder and CEO Vasu Nadella said that he got interested in the space because he and his co-founders have watched family members deal with chronic illness and know that being able to get quick diagnostic results is crucial for treatment.

Plus, Nadella wanted to know why companies couldn’t seem to get the solution to this problem right. While Theranos failed for a variety of reasons, the other companies trying to build these quicker blood diagnostic tools had yet to ship products. He thought maybe he could crack the code.

The startup launched in 2019 and built quietly until it debuted its device at the American Association of Clinical Chemistry’s annual meeting — the industry’s “Super Bowl” — last Monday. Vital Bio also announced that it had raised $48 million in venture funding from Labcorp, Inovia Capital, Lachy Groom and Sam Altman, among others.

Nadella said the company has focused on making sure that its device produces accurate results and that when it does drift, they know how to prevent it from impacting the final diagnosis. He said the company waited to start talking about what it was up to until it felt it had enough to back up its claims.

from TechCrunch https://ift.tt/MIL0EzY

Comments

Ivella is the latest fintech focused on couples banking, with a twist

Money can make people moody. There are layers of privilege, or lack thereof, that can make even the simplest conversation about bills feel like baggage to deal with. Translate that discomfort to relationships and it can feel like an awkward — and fragmented — dance on who pays which bill when (and how). Ivella , a Santa Monica-based startup, wants to build banking products for couples to take away some of these tensions. Led by CEO and co-founder Kahlil Lalji , the startup is launching with a split account product that just raised $3.5 million in funding from Anthemis, Financial Venture Studio and Soma Capital. Other investors include Y Combinator, DoNotPay CEO Joshua Browder and Gumroad CEO Sahil Lavingia. Lalji, who helped creators with digital content before jumping into the world of fintech, says that the startup was born out of his own frustration at the expectation that couples would just use Venmo unless they were married. The best solution, so far, has been joint accounts...

A judge dismissed Phhhoto’s antitrust suit against Meta

A U.S. District Court Judge for the Eastern District of New York threw out a lawsuit against Meta this week that had been simmering for a year and a half. The suit, filed in late 2021 by now-shuttered social app Phhhoto, alleged that Meta violated federal antitrust law by copying its core features with the Instagram-adjacent video looping app Boomerang . Like Boomerang, which Meta launched in October of 2015 and later integrated into Instagram itself, Phhhoto invited users to share very short GIF-like loops. U.S. District Judge Kiyo Matsumoto ultimately granted Meta’s motion to dismiss the complaint due to time-limits imposed by the relevant statutes of limitations. “Phhhoto has failed in its 69-page Amended Complaint of 222 paragraphs to allege sufficient facts that cure the untimeliness of all of its federal claims,” Matsumoto wrote in the opinion, calling the possibility of any amendment to resolve the issue of the lawsuit’s timing “futile.” New antitrust suit from Phhhoto a...

6 VCs explain why embedded insurance isn’t the only hot opportunity in insurtech

If you think embedded insurance is the only hot thing in insurtech these days, we’ve got a surprise in store for you: While it’s true that startups that help sell insurance together with other products and services are enjoying tailwinds, there are plenty of other opportunities in the space, several investors told TechCrunch+. You see, insurtech startups often need to take into account the myriad rules and regulations in place when they seek to innovate and embed insurance into products, which might make it difficult to pull it off. And given the current emphasis on achieving cost efficiency to extend runways in the broader startup ecosystem, it appears investors are open to insurtech startups that can build a sustainable business model, regardless of it including embedded insurance. “Insurtech startups that do not offer embedded insurance, and rather provide other innovative solutions will still attract VC funding this year, especially if they can show cost-efficient and sustainabl...

Kkshingh

Search This Blog

Deck.blue brings a TweetDeck experience to Bluesky users